A Randomized Controlled Clinical Trial to evaluate the efficacy of Jatiphala Lepa (Myristica fragrans) and Arjun Twak Lepa (Terminalia arjuna) with Honey in the management of Vyanga(Melasma).

Dr Megha Champati Sawle0 sites0 target enrollmentTBD

ConditionsHealth Condition 1: L814- Other melanin hyperpigmentation

Overview

Phase: Phase 2
Intervention: Not specified
Conditions: Health Condition 1: L814- Other melanin hyperpigmentation
Sponsor: Dr Megha Champati Sawle
Status: Recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Investigators

Sponsor

Dr Megha Champati Sawle

Eligibility Criteria

Inclusion Criteria

•Patients with signs and symptoms of vyanga\- ruksha (dryness),khara, krushana varya(blackish edges),rakta varya(reddish edges), kandu (itching), daha(burning).

Exclusion Criteria

•Vyanga along with kustharoga to be excluded.
•Hyper pigmentation caused since birth.
•Pregnant \& lactating women.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting

Phase 2

To Study the effectiveness between Bilvadi Panchamoola Churna andGuduchyadi Churna in the management of Sthaulya [Overweight] in children of age group 8 to 15yearsHealth Condition 1: E663- Overweight

CTRI/2023/11/060152Dr Pooja Mahadev Mukadam

Not yet recruiting

Phase 3

Drakshadi yoga in the management of Kaphaja Kasa

CTRI/2018/02/012160KAHER Shri B M K Ayurveda Mahavidyalaya

Not yet recruiting

Phase 2

A Randomized Clinical Controlled Trial to evaluatethe efficacy of Khadiradi Ointment on Dadru(Tinea Infections) in childreHealth Condition 1: L088- Other specified local infections of the skin and subcutaneous tissueHealth Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue

CTRI/2024/02/063214Dr Ravindra Ramchandra Rajpal

Completed

Phase 2

Dhoopan or Fumigation in Itching vulvaHealth Condition 1: N768- Other specified inflammation of vagina and vulva

CTRI/2019/07/020104All India Institute of Ayurveda60

Completed

Phase 2

A clinical trial to study the effects of a poly-herbal compound on immune status of healthy human subjects

CTRI/2022/05/042366Ms Saatvik Enterprises60